Showing 15 of 15 recruiting trials for “hereditary-angioedema-with-normal-c1inh”
Donidalorsen Treatment in Children With Hereditary Angioedema
A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
A Study of Navenibart in Participants With Hereditary Angioedema
Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
HAE Burden and Crisis Management
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
👨⚕️ Study Director, Pharvaris, Pharvaris Netherlands B.V.📍 24 sites📅 Started Feb 2025View details ↗
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
Enrolling by InvitationNCT06262399 ↗
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
👨⚕️ Vesna Grivcheva-Panoska, MD, PhD, PHI University Clinic of Dermatology📍 16 sites📅 Started Jul 2021View details ↗
Deployment o the Multidisciplinary Prospective Cohort Imminent
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →